18 Sep 2024
Doherty Seminar Series - Dr David Persing (Cepheid)
WHEN
08 Oct 2024
12.30 - 1.30pm
WHERE
Auditorium, The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne VIC 3000
The Doherty Institute is proud to host Dr David Persing (Executive Vice President and Chief Medical and Scientific Officer, Cepheid) as he presents on 'Decentralized Molecular Diagnostics - Challenges and Opportunities'.
Light lunch and refreshments will be provided at the event.
About Dr David Persing
Dave joined Cepheid in 2005 where he developed an industry-leading portfolio of products focused on the enablement of molecular diagnostic technology to meet global challenges in infectious diseases and oncology. He conducted his scientific and medical training with Don Ganem and Nobel laureate Harold Varmus at the University of California, San Francisco, and obtained his MD and PhD degrees in 1988. After residency training in Laboratory Medicine at Yale, he held leadership roles in academia and industry starting in the early 1990s with the design, implementation, and scaleup of the first PCR reference laboratory at the Mayo Clinic. His interest in the democratization of molecular diagnostic methods has been longstanding, starting in 1993 with his publication of the first of five widely adopted textbooks to include PCR protocols and guidelines for laboratory operations. He has published over 300 peer-reviewed articles and reviews, including multiple high impact publications in the New England Journal of Medicine, Science, and PNAS. In 2020, he was named to the Fierce Pharma list of the 22 most influential scientists in the fight against COVID-19. To maintain a connection with the latest trends in translational medicine, Dave also serves as Consulting Professor of Pathology at Stanford University School of Medicine.